These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 17889845

  • 1. Predictive value of osteocalcin and beta-CrossLaps in metastatic breast cancer.
    Salem AM, Zohny SF, Abd El-Wahab MM, Hamdy R.
    Clin Biochem; 2007 Nov; 40(16-17):1201-8. PubMed ID: 17889845
    [Abstract] [Full Text] [Related]

  • 2. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D, Siepmann S, Geppert R, Wernecke KD, Possinger K, Lüftner D.
    Anticancer Res; 2007 Nov; 27(4A):1853-62. PubMed ID: 17649784
    [Abstract] [Full Text] [Related]

  • 3. [Clinical evaluation of serum osteocalcin in patients with bone metastasis of breast cancer].
    Suzuki S, Nomizu T, Nihei M, Rokkaku Y, Kimijima I, Tsuchiya A, Abe R.
    Nihon Gan Chiryo Gakkai Shi; 1989 Oct 20; 24(10):2386-93. PubMed ID: 2614177
    [Abstract] [Full Text] [Related]

  • 4. Clinical value of TPS, CEA and CA 15-3 in breast cancer patients.
    Blijlevens NM, Oosterhuis WP, Oosten HR, Mulder NH.
    Anticancer Res; 1995 Oct 20; 15(6B):2711-6. PubMed ID: 8669851
    [Abstract] [Full Text] [Related]

  • 5. [Diagnostic value of combined detection of TPS, CA153 and CEA in breast cancer].
    Zheng H, Luo RC.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct 20; 25(10):1293-4, 1298. PubMed ID: 16234113
    [Abstract] [Full Text] [Related]

  • 6. Importance of CEA and CA 15-3 during disease progression in metastatic breast cancer patients.
    Laessig D, Nagel D, Heinemann V, Untch M, Kahlert S, Bauerfeind I, Stieber P.
    Anticancer Res; 2007 Oct 20; 27(4A):1963-8. PubMed ID: 17649806
    [Abstract] [Full Text] [Related]

  • 7. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
    Ławicki S, Szmitkowski M, Wojtukiewicz M.
    Clin Chim Acta; 2006 Sep 20; 371(1-2):112-6. PubMed ID: 16631152
    [Abstract] [Full Text] [Related]

  • 8. A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.
    Guadagni F, Ferroni P, Carlini S, Mariotti S, Spila A, Aloe S, D'Alessandro R, Carone MD, Cicchetti A, Ricciotti A, Venturo I, Perri P, Di Filippo F, Cognetti F, Botti C, Roselli M.
    Clin Cancer Res; 2001 Aug 20; 7(8):2357-62. PubMed ID: 11489813
    [Abstract] [Full Text] [Related]

  • 9. Predictive value of CEA and CA 15-3 in the follow up of invasive breast cancer.
    Sütterlin M, Bussen S, Trott S, Caffier H.
    Anticancer Res; 1999 Aug 20; 19(4A):2567-70. PubMed ID: 10470196
    [Abstract] [Full Text] [Related]

  • 10. Long-term follow-up study in breast cancer patients using serum tumor markers CEA and CA 15-3.
    Lumachi F, Brandes AA, Boccagni P, Polistina F, Favia G, D'Amico DF.
    Anticancer Res; 1999 Aug 20; 19(5C):4485-9. PubMed ID: 10650797
    [Abstract] [Full Text] [Related]

  • 11. Preoperative high type I collagen degradation marker ICTP reflects advanced breast cancer.
    Keskikuru R, Kataja V, Kosma VM, Eskelinen M, Uusitupa M, Johansson R, Risteli L, Risteli J, Jukkola A.
    Anticancer Res; 1999 Aug 20; 19(5C):4481-4. PubMed ID: 10650796
    [Abstract] [Full Text] [Related]

  • 12. Total procollagen type 1 amino-terminal propeptide (total P1NP) as a bone metastasis marker in gynecological carcinomas.
    Oremek G, Sauer-Eppel H, Klepzig M.
    Anticancer Res; 2007 Aug 20; 27(4A):1961-2. PubMed ID: 17649805
    [Abstract] [Full Text] [Related]

  • 13. Predictive value of osteocalcin in bone metastatic differentiated thyroid carcinoma.
    Gao Y, Lu H, Luo Q, Wu X, Sheng S.
    Clin Biochem; 2010 Feb 20; 43(3):291-5. PubMed ID: 19732762
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of serum KL-6, a mucin-like glycoprotein, as a tumor marker for breast cancer.
    Ogawa Y, Ishikawa T, Ikeda K, Nakata B, Sawada T, Ogisawa K, Kato Y, Hirakawa K.
    Clin Cancer Res; 2000 Oct 20; 6(10):4069-72. PubMed ID: 11051258
    [Abstract] [Full Text] [Related]

  • 15. Validity of bone marker measurements for monitoring response to bisphosphonate therapy with zoledronic acid in metastatic breast cancer.
    Aktas B, Kasimir-Bauer S, Lehmann N, Kimmig R, Tewes M.
    Oncol Rep; 2013 Jul 20; 30(1):441-7. PubMed ID: 23604361
    [Abstract] [Full Text] [Related]

  • 16. Combined measurement of serum sialyl Lewis X with serum CA15-3 in breast cancer patients.
    Kurebayashi J, Nomura T, Hirono M, Okubo S, Udagawa K, Shiiki S, Ikeda M, Nakashima K, Tanaka K, Sonoo H.
    Jpn J Clin Oncol; 2006 Mar 20; 36(3):150-3. PubMed ID: 16520359
    [Abstract] [Full Text] [Related]

  • 17. The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor load.
    Generali D, Berruti A, Tampellini M, Dovio A, Tedoldi S, Bonardi S, Tucci M, Allevi G, Aguggini S, Milani M, Bottini A, Dogliotti L, Angeli A.
    Bone; 2007 Jan 20; 40(1):182-8. PubMed ID: 16935041
    [Abstract] [Full Text] [Related]

  • 18. Comparison of CEA, MCA, CA 15-3 and CA 27-29 in follow-up and monitoring therapeutic response in breast cancer patients.
    Lauro S, Trasatti L, Bordin F, Lanzetta G, Bria E, Gelibter A, Reale MG, Vecchione A.
    Anticancer Res; 1999 Jan 20; 19(4C):3511-5. PubMed ID: 10629644
    [Abstract] [Full Text] [Related]

  • 19. Metabolic gaps in bone formation may be a novel marker to monitor the osseous metastasis of prostate cancer.
    Koizumi M, Yonese J, Fukui I, Ogata E.
    J Urol; 2002 Apr 20; 167(4):1863-6. PubMed ID: 11912449
    [Abstract] [Full Text] [Related]

  • 20. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
    Schatz C, von Lieven H, Mulders M, Rowold J, Stracke H, Müller H, Grebe SF, Schatz H.
    Wien Klin Wochenschr; 1985 Dec 06; 97(23):873-9. PubMed ID: 3878042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.